GoodRx Holdings, Inc.
August 18, 2025 - by Joey Ramson
$GDRX is up today on news that it has entered into a collaboration with Novo Nordisk to expand access to Ozempic® and Wegovy® for $499-Per-Month. Shares have had trouble closing above $5 on its weekly chart for almost a year. If it can hold that this week it would be a further bullish sign.
